Private Equity Round in 2023
Operator of a design-centric agency and commercialization platform focused on the healthcare sector. The company offers ground-up brand and campaign development, brand launches, and creative advertising campaigns to world-class design, strategic positioning, leading-edge omnichannel capabilities, as well as data and analytics services.
Private Equity Round in 2021
Operator of a physician practice management firm providing business support services for top-tier fertility programs across the United States. The company offers a variety of technology platforms to effectively manage clinical and business information systems, facilities and operations, finance and accounting, physician recruitment and credentialing, legal, risk management, lab operations, business development, fertility treatment financing programs and other services that support fertility focused domestic and international physician practices to drive innovation and leverage best practices to enhance both the patient experience and treatment outcomes.
Private Equity Round in 2021
SSI Strategy is a management consulting firm that specializes in providing services to life science companies, focusing on medical affairs, pharmacovigilance, and clinical development. Established in 2010 and headquartered in Parsippany, New Jersey, the firm also has offices in Cambridge, Massachusetts; London; New York; and San Francisco. SSI Strategy offers a range of services including global medical affairs transformation, competency model development, post-merger integration, launch preparation, and enhancements to pharmacovigilance systems. The firm leverages its expertise in business, medical, clinical, and pharmacovigilance domains to support clients in managing pharmaceutical product life cycles, business development, and new product launch strategies, thereby ensuring operational continuity in critical safety and medical activities during organizational changes.
Private Equity Round in 2020
SSI Strategy is a management consulting firm that specializes in providing services to life science companies, focusing on medical affairs, pharmacovigilance, and clinical development. Established in 2010 and headquartered in Parsippany, New Jersey, the firm also has offices in Cambridge, Massachusetts; London; New York; and San Francisco. SSI Strategy offers a range of services including global medical affairs transformation, competency model development, post-merger integration, launch preparation, and enhancements to pharmacovigilance systems. The firm leverages its expertise in business, medical, clinical, and pharmacovigilance domains to support clients in managing pharmaceutical product life cycles, business development, and new product launch strategies, thereby ensuring operational continuity in critical safety and medical activities during organizational changes.
OPEN Health is a healthcare communications and market access agency that provides a range of services to the pharmaceutical and life sciences sectors. Founded in 2011 and headquartered in Chicago, Illinois, with offices in the United Kingdom, the Netherlands, Germany, India, and China, the company specializes in consulting, digital marketing communications, medical education, public relations, and data consultancy. OPEN Health also offers expertise in market access strategy, health economic modeling, real-world evidence, patient engagement, and scientific communications. With a workforce of around 200 professionals, the agency collaborates with numerous top pharmaceutical companies, as well as various healthcare organizations, from startups to multinational corporations, delivering tailored solutions on both regional and global scales.
Children’s Choice providing access to quality engaging care to children.
Private Equity Round in 2018
Peloton Advantage, LLC is a medical communication company based in Parsippany, New Jersey, founded in 2005. It specializes in strategic publication planning and content development for medical education programs, offering services that include strategic communication plans, enduring content, and live events. The company has established a strong presence in the industry, earning several awards for its growth and excellence in service delivery. Peloton Advantage employs over 80 professionals who support both US and global accounts, catering to a diverse range of pharmaceutical, biotechnology, and medical device companies. The firm contributes to the success of more than 90 products across various therapeutic areas, including cardiovascular and infectious diseases, and plays a vital role in the communication strategies of its clients.
SynteractHCR Holdings Corp. is a full-service contract research organization based in Carlsbad, California, established in 2008. With over two decades of experience, it supports biotechnology, medical device, and pharmaceutical companies throughout all phases of clinical development. The company emphasizes a collaborative approach through its “Shared Work – Shared Vision” philosophy, enabling it to provide customized services from Phase I to Phase IV efficiently and cost-effectively. Operating in 16 countries, SynteractHCR conducts international clinical trials and offers expertise in various therapeutic areas, including oncology, central nervous system disorders, infectious diseases, endocrinology, cardiovascular, and respiratory conditions, ensuring timely delivery of quality data to facilitate faster decision-making for its clients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.